S100B 或可作为非节段性白癜风疾病活动度标志物
该研究检测非节段性白癜风患者血清 S100B 水平,发现活动期患者血清 S100B 显著升高,并与受累体表面积强相关;前瞻性随访提示血清 S100B 对疾病进展有预测价值。体外实验显示黑素细胞在反复冻融后细胞内 S100B 上调、随后大量释放,或可解释活动期血清 S100B 升高;MBEH 诱导白癜风小鼠模型提示抑制 S100B 可能成为治疗策略。
要点
- 活动期非节段性白癜风患者血清 S100B 显著升高,且与受累体表面积强相关。
- 血清 S100B 水平对疾病进展具有预测价值,或可辅助评估疾病活动度。
- 抑制 S100B 在白癜风小鼠模型中显示治疗潜力,S100B 或为潜在治疗靶点。
核心结论
- S100B 可能作为非节段性白癜风疾病活动度的生物标志物。
- S100B 这种损伤相关分子模式蛋白可能在白癜风发病机制中发挥重要作用,并可能成为潜在的新治疗靶点。
研究设计与样本
- 研究检测非节段性白癜风患者血清 S100B 水平,并进行前瞻性随访。
- 体外实验采用反复冻融处理正常与白癜风黑素细胞。
- 采用 MBEH 诱导的白癜风小鼠模型评估抑制 S100B 的作用。
主要发现
- 活动期非节段性白癜风患者血清 S100B 水平显著升高。
- 血清 S100B 水平与受累体表面积强相关。
- 前瞻性随访显示血清 S100B 水平对疾病进展具有预测价值。
- 反复冻融后正常与白癜风黑素细胞细胞内 S100B 上调,随后大量释放至环境中。
- MBEH 诱导白癜风小鼠模型显示抑制 S100B 具有治疗潜力。
临床怎么用
- 可考虑将血清 S100B 作为评估非节段性白癜风疾病活动度与进展风险的候选生物标志物。
- S100B 抑制作为白癜风治疗策略仍需进一步临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitiligo is a chronic skin condition characterized by progressive depigmentation of the skin. S100B is a damage-associated molecular pattern protein expressed in melanocytes that has been proposed as a marker of melanocyte cytotoxicity. Although the use of S100B as a biomarker in melanoma is well established, to our knowledge its association with vitiligo activity has not yet been investigated. Here, we show that S100B serum levels were significantly increased in patients with active nonsegmental vitiligo and strongly correlated with the affected body surface area. Prospective follow-up showed a predictive value of serum S100B levels on disease progression. In vitro experiments using repeated freeze-thaw procedures showed an intracellular up-regulation of S100B in normal and vitiligo melanocytes before an extensive release in the environment. This phenomenon may explain the increased S100B serum values in the active phase of vitiligo. In a monobenzone-induced vitiligo mouse model we could show the potential of S100B inhibition as a therapeutic strategy in vitiligo. In conclusion, this report shows the possible use of S100B as a biomarker for disease activity in vitiligo. Our data suggest that this damage-associated molecular pattern protein could play a substantial role in the pathogenesis of vitiligo and may be a potential new target for treatment.
引用
- Speeckaert R, Voet S, Hoste E, et al. S100B Is a Potential Disease Activity Marker in Nonsegmental Vitiligo. J Invest Dermatol. 2017. PMID: 28212812. doi:10.1016/j.jid.2017.01.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。